Log In
Wednesday 21st March 2018

NICE issues guidance on FH

26th September 2008

The National Institute for Health and Clinical Excellence has issued guidance which recommends considering the possibility of familial hypercholesterolaemia (FH) in all patients with raised total cholesterol, especially if there is a personal or family history of premature CHD.

It says that following a clinical diagnosis of FH, cascade testing to help identify relatives who will benefit from early treatment should be initiated. NICE say it is important to inform patients that lipid-modifying drug therapy should be lifelong and to discuss the various treatment options.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018